Can metoprolol tartrate (metoprolol) be dosed once a day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metoprolol Tartrate Dosing Frequency

Metoprolol tartrate should typically be dosed twice daily rather than once daily due to its relatively short half-life, unlike metoprolol succinate which is specifically formulated for once-daily dosing.

Pharmacokinetic Considerations

Metoprolol tartrate has a relatively short half-life that makes it unsuitable for once-daily dosing in most clinical scenarios:

  • Metoprolol tartrate has a half-life of approximately 3-7 hours, which is insufficient to maintain therapeutic blood levels over 24 hours 1
  • Guidelines from the American College of Cardiology/American Heart Association specifically list metoprolol tartrate with a recommended dosing frequency of twice daily 2
  • In contrast, metoprolol succinate (extended-release) is specifically formulated for once-daily dosing through a controlled-release mechanism 3

Evidence from Guidelines

Multiple cardiovascular guidelines consistently recommend twice-daily dosing for metoprolol tartrate:

  • The 2017 ACC/AHA hypertension guideline explicitly lists metoprolol tartrate with a daily frequency of "2" (twice daily) 2
  • For acute management of supraventricular tachycardia, metoprolol tartrate is administered as 2.5-5.0 mg IV bolus over 2 minutes, which can be repeated in 10 minutes up to 3 doses 2
  • When transitioning from IV to oral therapy, Praxis Medical Insights recommends starting with metoprolol 25mg orally every 6 hours for 48 hours before transitioning to maintenance dosing 4

Clinical Implications

Using metoprolol tartrate once daily may lead to:

  • Inadequate beta-blockade during the latter part of the 24-hour period
  • Fluctuating blood pressure control in hypertensive patients
  • Inconsistent protection against angina symptoms
  • Potential for rebound effects as drug levels decrease before the next dose

Alternative Options

If once-daily dosing is preferred for patient convenience or adherence:

  1. Switch to metoprolol succinate: This extended-release formulation is specifically designed for once-daily dosing with equivalent beta-blocking effects 3

    • A 100mg metoprolol succinate tablet is equivalent to 100mg of metoprolol tartrate but provides steady drug release over approximately 20 hours
  2. Consider other beta-blockers with longer half-lives:

    • Bisoprolol (once daily)
    • Atenolol (once daily)
    • Nadolol (once daily)
    • Carvedilol phosphate (once daily)

Special Considerations

While some early research suggested that once-daily metoprolol tartrate might be possible in certain hypertension cases 1, subsequent clinical practice and guidelines have consistently recommended twice-daily dosing for optimal therapeutic effect.

For patients where adherence is a concern with twice-daily dosing, switching to metoprolol succinate would be the preferred approach rather than attempting once-daily dosing with metoprolol tartrate.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cardiovascular Medication Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.